Inogen | INGN - Ordinary Share Capital


Inogen reported $23K in Ordinary Share Capital for its fiscal quarter ending in December of 2023.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
AngioDynamics USD 385K 1000 Feb/2025
AtriCure USD 49.7M 10K Sep/2025
Baxter International USD 683M 0 Dec/2024
Becton, Dickinson and Co. USD 284.91M 1.72M Dec/2025
Boston Scientific USD 1.48B 1.46B Jun/2025
Chart Industries USD 44.95M 7K Sep/2025
Cooper Companies USD 198.81M 9K Sep/2025
Dexcom USD 392.2M 391.8M Jun/2025
Edwards Lifesciences USD 580.7M 7.2M Sep/2025
Globus Medical USD 135.05M 134.92M Jun/2025
Inogen USD 23K 0 Dec/2023
Insulet USD 70.35M 70.25M Sep/2025
Masimo USD 53.1M 1.2M Sep/2025
Medtronic USD 1.28B 66K Jun/2025
Orthofix International USD 3.82M 17K Sep/2024
Philips EUR 951.29M 310K Dec/2025
ResMed USD 145.97M 25K Dec/2025
Steris USD 98.15M 344K Dec/2025
Stryker USD 382.4M 93K Dec/2025
Tandem Diabetes Care USD 67.77M 242K Sep/2025
Teleflex USD 44.19M 482K Jun/2025
X T L Biopharmaceuticals USD 881.39M 858.25M Jun/2025
Zimmer Biomet Holdings USD 198.18M 18.44K Dec/2025